BD (NYSE:BDX) announced that it opened a new facility in Ireland and committed a further investment within the country.
Last week, the company held a grand opening ceremony for a new $4.3 million (€4 million) R&D facility in Blackrock, Dublin. BD also announced an additional $32.1 million (€30 million) investment to expand its Enniscorthy, Wexford manufacturing facility.
The Blackrock facility’s focus centers around the commercialization of BD’s first on-body injector device, the Evolve. It also serves as the regional base of operations for sales, technical service and corporate functional support teams.